Beta-Adrenergic Signaling Impairs Anti-Tumor CD8+ T Cell Responses to B Cell Lymphoma Immunotherapy
Cancer immunology research - United States
doi 10.1158/2326-6066.cir-17-0401
Full Text
Open PDFAbstract
Available in full text
Date
November 16, 2017
Authors
Publisher
American Association for Cancer Research (AACR)